Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing insulin glargine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Insulin glargine 100iu/mL injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
|
Insulin glargine 100u/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
|
Insulin glargine 100units/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
|
Insulin glargine 100units/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
|
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
|
Product containing precisely human insulin (as insulin glargine) 1000 unit/10 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as insulin glargine) 300 unit/3 milliliter conventional release solution for injection cartridge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as insulin glargine) 300 unit/3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Product containing insulin glargine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Product containing only insulin glargine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Insulin glargine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as insulin glargine) 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Insulin glargine 100 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Insulin glargine 100 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely insulin glargine 300 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely insulin glargine 300 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Insulin glargine (substance) |
Inferred relationship |
Some |
1 |